ARG1 and cholangiocarcinoma: Targeting these metabolic pathways (such as GLS1, ARG1, PHGDH, IDO1, etc.)may restore the function of immune cells, inhibit tumor progression, and provide new strategies for the treatment of cholangiocarcinoma.